<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Use of Contrast-Enhanced Spectral Mammography for Intramammary Cancer Staging" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/use-of-contrast-enhanced-spectral-mammography-for-intramammary-cancer-staging/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/use-of-contrast-enhanced-spectral-mammography-for-intramammary-cancer-staging/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2014-10-31T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Use of Contrast-Enhanced Spectral Mammography for Intramammary Cancer Staging" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-10T02:43:55+00:00","datePublished":"2014-10-31T17:00:00+00:00","description":"Rationale and Objectives","headline":"Use of Contrast-Enhanced Spectral Mammography for Intramammary Cancer Staging","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/use-of-contrast-enhanced-spectral-mammography-for-intramammary-cancer-staging/"},"url":"https://clinicaltree.github.io/posts/use-of-contrast-enhanced-spectral-mammography-for-intramammary-cancer-staging/"}</script><title>Use of Contrast-Enhanced Spectral Mammography for Intramammary Cancer Staging | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Use of Contrast-Enhanced Spectral Mammography for Intramammary Cancer Staging</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Use of Contrast-Enhanced Spectral Mammography for Intramammary Cancer Staging</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1414774800" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Oct 31, 2014 </em> </span> <span> Updated <em class="" data-ts="1681094635" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 10, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Katrin S. Blum MD</a> </em>, <em> <a href="">Christian Rubbert MD</a> </em>, <em> <a href="">Britta Mathys MD</a> </em>, <em> <a href="">Gerald Antoch MD</a> </em>, <em> <a href="">Svjetlana Mohrmann MD</a> </em>, <em> <a href="">Silvia Obenauer MD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="1705 words"> <em>9 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>To prospectively evaluate and compare the accuracy of contrast-enhanced spectral mammography (CESM) and ultrasound (US) in size measurement of breast cancer with histologic tumor sizes as gold standard.</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Twenty women aged between 40–73 years (mean age, 57 ± 10 years) with histologically proven invasive ductal/lobular carcinomas were included in the study. Agreement between imaging tumor size (CESM and US) and histopathologic tumor size was evaluated with Bland–Altman analysis. Stereotactically guided vacuum biopsy was performed in four patients after CESM. Two independent reviewers described artifacts of CESM.</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Motion artifacts did not occur in the study. CESM-specific artifacts caused by scattered radiation mostly occurred in oblique view of CESM. Background enhancement of breast tissue was seen in four patients. Mean difference of tumor sizes was 0.3 mm (6.34%) between CESM and histology and −2.2 mm (−7.59%) between US and histology. Limits of agreement ranged from −18.9 to 19.48 mm for CESM and from −17.1 to 12.7 mm with US. Especially smaller tumors with a size &lt;23 mm were measured more precisely with CESM. Enhancement of breast tissue around microcalcifications correlated with abnormalities.</p><h2 id="conclusions"><span class="mr-2">Conclusions</span><a href="#conclusions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>CESM is accurate in size measurements of small breast tumors. On average CESM leads to a slight overestimation of tumor size, whereas US tends to underestimate tumor size. Assessment of the breast tissue can be limited by the scattered radiation artifact and background enhancement of breast tissue. CESM seems to be helpful in the characterization of breast tissue around microcalcifications.</p><p>Contrast-enhanced spectral mammography (CESM) is an imaging technique combining digital mammography with intravenous injection of iodinated contrast media to detect hypervascularized lesions, especially in dense breast tissue . Although it was developed several years ago, knowledge about the performance of this technique in clinical routine, especially in breast cancer screening, is still limited. However, a recent study proposes similar indications for CESM as for magnetic resonance imaging (MRI), namely preoperative staging, detection of occult lesions, monitoring of treatment response . Initial results comparing this new technique with mammography, ultrasound (US) and breast MRI show a better detection of suspicious lesions with CESM compared to full-field digital mammography and the combined imaging of mammography and US but a lower detection rate of hypervascularized breast lesions compared to breast MRI . Studies evaluating the accuracy of CESM compared to MRI in preoperative tumor staging show a similar accuracy in lesion size measurement compared to MRI .</p><p>Preoperative staging of cancer extent in the breast is necessary to plan the optimal treatment . MRI is the most commonly used approach to determine the extent of the tumor in the breast and to decide which surgery should be performed and if the breast should be radiated . Besides its high cost and limited availability, one major problem of breast MRI is background enhancement of breast tissue, which decreases the detection of breast lesions and affects breast cancer staging . In such patients, US is a good alternative method for breast cancer staging. Studies correlating tumor size determined with imaging and histopathology describe a tendency to underestimate tumor size with US , whereas MRI tends to overestimate tumor size . The good performance of CESM in the detection of multifocal and multicentric cancer dissemination has been shown , as well as the high accuracy of tumor size measurements with CESM compared to MRI . The performance of CESM in preoperative tumor size measurement compared to US has not been investigated so far.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="material-and-methods"><span class="mr-2">Material and methods</span><a href="#material-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="patients"><span class="mr-2">Patients</span><a href="#patients" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="cesm-imaging"><span class="mr-2">CESM Imaging</span><a href="#cesm-imaging" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="ultrasound"><span class="mr-2">Ultrasound</span><a href="#ultrasound" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="image-analysis"><span class="mr-2">Image Analysis</span><a href="#image-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="contrast-enhanced-spectral-mammography"><span class="mr-2">Contrast-Enhanced Spectral Mammography</span><a href="#contrast-enhanced-spectral-mammography" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="statistical-analysis"><span class="mr-2">Statistical Analysis</span><a href="#statistical-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 1</p><p>Details of Patients Included in the Study</p><p>Number of Patients Age (Mean Age; Standard Deviation) Disease ACR (Artifacts) ACR2 ACR3 ACR 4 20 40–73 (57; 10) Invasive cancer 2 4 1 Invasive cancer with EIC 4 (1) 6 3 (2)</p><p>The majority of patients had invasive cancer with additional extensive in-situ component (EIC).</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="artifacts"><span class="mr-2">Artifacts</span><a href="#artifacts" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/UseofContrastEnhancedSpectralMammographyforIntramammaryCancerStaging/0_1s20S1076633214002414.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/UseofContrastEnhancedSpectralMammographyforIntramammaryCancerStaging/0_1s20S1076633214002414.jpg" alt="Figure 1, Low-energy mammography (a) and processed CESM (b) oblique mammography (RMLO) and craniocaudal view (RCC; c and d ) of the right breast of a woman with invasive ductal breast cancer. Scattered radiation artifact is marked with arrows , appears more prominent in RMLO view, and does not affect tumor size measurement. CESM, contrast-enhanced spectral mammography; RCC, right craniocaudal; RMLO, right mediolateral." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="background-parenchymal-enhancement-of-breast-tissue"><span class="mr-2">Background Parenchymal Enhancement of Breast Tissue</span><a href="#background-parenchymal-enhancement-of-breast-tissue" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/UseofContrastEnhancedSpectralMammographyforIntramammaryCancerStaging/1_1s20S1076633214002414.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/UseofContrastEnhancedSpectralMammographyforIntramammaryCancerStaging/1_1s20S1076633214002414.jpg" alt="Figure 2, Processed contrast-enhanced spectral mammography in (a) craniocaudal (LCC) and (b) oblique view (LMLO) in a woman with invasive ductal breast cancer with additional extensive intraductal component. The arrows mark the tumor; asterisks (*) mark enhancing foci retroareolar. Additional non-mass enhancement medial in the breast (**) is caused most likely because of hormonal proliferation. LCC, left craniocaudal; LMLO, left mediolateral." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="cesm-before-stereotactically-guided-vacuum-assisted-core-biopsy-of-the-breast"><span class="mr-2">CESM Before Stereotactically Guided Vacuum-Assisted Core Biopsy of the Breast</span><a href="#cesm-before-stereotactically-guided-vacuum-assisted-core-biopsy-of-the-breast" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/UseofContrastEnhancedSpectralMammographyforIntramammaryCancerStaging/2_1s20S1076633214002414.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/UseofContrastEnhancedSpectralMammographyforIntramammaryCancerStaging/2_1s20S1076633214002414.jpg" alt="Figure 3, (a) Low-energy mammography of contrast-enhanced spectral mammography (CESM) of a woman with histological proven cancer in the upper part of the breast with suspicious microcalcifications (*). Additional suspicious microcalcifications are detected in the anterior third of breast tissue in the upper part of the breast ( arrow in the magnification of a in b ). Processed CESM image (c) with enhancement of the tumor and around the additional microcalcifications ( arrow in the magnification of c in d ). (e) Stereotactic-guided vacuum biopsy of the additional microcalcification, which turned out to be a ductal carcinoma in situ." class="lazyload" data-proofer-ignore></a></p><p>Table 2</p><p>Histopathologic Results of Four Patients with Suspicious Microcalcifications, Which Received CESM before Stereotactic-Guided Vacuum Biopsy</p><p>Patients Primary Cancer Type Enhancement Around Microcalcifications Histopathologic Finding Invasive lobular cancer N Fibrocystic mastopathy, ductal hyperplasia, and sclerosing adenosis N Fibrocystic mastopathy, ductal hyperplasia, and sclerosing adenosis Invasive ductal cancer N Fibrocystic mastopathy, ductal hyperplasia, and chronic inflammation Invasive ductal cancer Y Atypical lobular hyperplasia (ALH) ∗ N Fibrocystic mastopathy and ductal hyperplasia Invasive ductal cancer Y DCIS ∗</p><p>CESM, contrast-enhanced spectral mammography; DCIS, ductal carcinoma in situ.</p><p>CESM showed enhancement surrounding microcalcifications in two patients, one with DCIS and one with ALH. Both lesions were excised.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="no-significant-influence-of-additional-eic-on-tumor-size-measurements-of-invasive-breast-cancers"><span class="mr-2">No Significant Influence of Additional EIC on Tumor Size Measurements of Invasive Breast Cancers</span><a href="#no-significant-influence-of-additional-eic-on-tumor-size-measurements-of-invasive-breast-cancers" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 3</p><p>Comparison of the Differences Between Measured Tumor Size with Imaging and Histopathology</p><p>Tumor Type Ultrasound CESM Mean (mm) LOA (mm) Mean (mm) LOA (mm) Invasive cancer ( <em>n</em> = 7) −1.571 −19.48 to 14.4 −0.714 −11.15 to 9.72 Invasive cancer + EIC ( <em>n</em> = 13) −2.538 −12.82 to 9.67 0.846 −22.06 to 23.75 Total ( <em>n</em> = 20) −2.2 −17.1 to 12.7 0.3 −18.88 to 19.48</p><p>CESM, contrast-enhanced spectral mammography; EIC, extensive in situ component; LOA, limits of agreement.</p><p><em>t</em> Test showed no significant under- or over-estimation of tumor size ( <em>P</em> &lt; .05).</p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/UseofContrastEnhancedSpectralMammographyforIntramammaryCancerStaging/3_1s20S1076633214002414.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/UseofContrastEnhancedSpectralMammographyforIntramammaryCancerStaging/3_1s20S1076633214002414.jpg" alt="Figure 4, Bland–Altman analysis of agreement of histologic tumor size with size measurements with contrast-enhanced spectral mammography (CESM) and ultrasound (US) in patients with invasive breast cancer with or without extensive intraductal component (EIC). High agreement of histologic tumor size and CESM measurements in patients with smaller tumors (≤22 mm). Additional EIC component did not affect tumor size measurements in either way." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Dromain C., Balleyguier C., Adler G., et. al.: Contrast-enhanced digital mammography. Eur J Radiol 2009; 69: pp. 34-42.</p><li><p>2. Lobbes M.B., Smidt M.L., Houwers J., et. al.: Contrast enhanced mammography: techniques, current results, and potential indications. Clin Radiol 2013; 68: pp. 935-944.</p><li><p>3. Dromain C., Thibault F., Muller S., et. al.: Dual-energy contrast-enhanced digital mammography: initial clinical results. Eur Radiol 2011; 21: pp. 565-574.</p><li><p>4. Jochelson M.S., Dershaw D.D., Sung J.S., et. al.: Bilateral contrast-enhanced dual-energy digital mammography: feasibility and comparison with conventional digital mammography and MR imaging in women with known breast carcinoma. Radiology 2013; 266: pp. 743-751.</p><li><p>5. Fallenberg E.M., Dromain C., Diekmann F., et. al.: Contrast-enhanced spectral mammography versus MRI: initial results in the detection of breast cancer and assessment of tumour size. Eur Radiol 2014; 24: pp. 256-264.</p><li><p>6. Litiere S., Werutsky G., Fentiman I.S., et. al.: Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol 2012; 13: pp. 412-419.</p><li><p>7. Pengel K.E., Loo C.E., Teertstra H.J., et. al.: The impact of preoperative MRI on breast-conserving surgery of invasive cancer: a comparative cohort study. Breast Cancer Res Treat 2009; 116: pp. 161-169.</p><li><p>8. Tendulkar R.D., Chellman-Jeffers M., Rybicki L.A., et. al.: Preoperative breast magnetic resonance imaging in early breast cancer: implications for partial breast irradiation. Cancer 2009; 115: pp. 1621-1630.</p><li><p>9. Uematsu T., Kasami M., Watanabe J.: Does the degree of background enhancement in breast MRI affect the detection and staging of breast cancer?. Eur Radiol 2011; 21: pp. 2261-2267.</p><li><p>10. Hieken T.J., Harrison J., Herreros J., et. al.: Correlating sonography, mammography, and pathology in the assessment of breast cancer size. Am J Surg 2001; 182: pp. 351-354.</p><li><p>11. Finlayson C.A., MacDermott T.A.: Ultrasound can estimate the pathologic size of infiltrating ductal carcinoma. Arch Surg 2000; 135: pp. 158-159.</p><li><p>12. Pritt B., Ashikaga T., Oppenheimer R.G., et. al.: Influence of breast cancer histology on the relationship between ultrasound and pathology tumor size measurements. Mod Pathol 2004; 17: pp. 905-910.</p><li><p>13. Gruber I.V., Rueckert M., Kagan K.O., et. al.: Measurement of tumour size with mammography, sonography and magnetic resonance imaging as compared to histological tumour size in primary breast cancer. BMC Cancer 2013; 13: pp. 328.</p><li><p>14. Uematsu T., Yuen S., Kasami M., et. al.: Comparison of magnetic resonance imaging, multidetector row computed tomography, ultrasonography, and mammography for tumor extension of breast cancer. Breast Cancer Res Treat 2008; 112: pp. 461-474.</p><li><p>15. Lobbes M.B., Nelemans P.J.: Good correlation does not automatically imply good agreement: the trouble with comparing tumour size by breast MRI versus histopathology. Eur J Radiol 2013; 82: pp. e906-e907.</p><li><p>16. Jiang Y.Z., Xia C., Peng W.T., et. al.: Preoperative measurement of breast cancer overestimates tumor size compared to pathological measurement. PLoS ONE 2014; 9: pp. e86676.</p><li><p>17. Schouten van der Velden A.P., Boetes C., Bult P., et. al.: The value of magnetic resonance imaging in diagnosis and size assessment of in situ and small invasive breast carcinoma. Am J Surg 2006; 192: pp. 172-178.</p><li><p>18. Grimsby G.M., Gray R., Dueck A., et. al.: Is there concordance of invasive breast cancer pathologic tumor size with magnetic resonance imaging?. Am J Surg 2009; 198: pp. 500-504.</p><li><p>19. Lobbes M.B., Lalji U., Houwers J., et. al.: Contrast-enhanced spectral mammography in patients referred from the breast cancer screening programme. Eur Radiol 2014; 24: pp. 1668-1676.</p><li><p>20. Fasching P.A., Heusinger K., Loehberg C.R., et. al.: Influence of mammographic density on the diagnostic accuracy of tumor size assessment and association with breast cancer tumor characteristics. Eur J Radiol 2006; 60: pp. 398-404.</p><li><p>21. Guinebretiere J.M., Le Monique G., Gavoille A., et. al.: Angiogenesis and risk of breast cancer in women with fibrocystic disease. J Natl Cancer Inst 1994; 86: pp. 635-636.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-21/'>Volume 21</a>, <a href='/categories/issue-11/'>Issue 11</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Use%20of%20Contrast-Enhanced%20Spectral%20Mammography%20for%20Intramammary%20Cancer%20Staging%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fuse-of-contrast-enhanced-spectral-mammography-for-intramammary-cancer-staging%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Use%20of%20Contrast-Enhanced%20Spectral%20Mammography%20for%20Intramammary%20Cancer%20Staging%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fuse-of-contrast-enhanced-spectral-mammography-for-intramammary-cancer-staging%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fuse-of-contrast-enhanced-spectral-mammography-for-intramammary-cancer-staging%2F&text=Use%20of%20Contrast-Enhanced%20Spectral%20Mammography%20for%20Intramammary%20Cancer%20Staging%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/a-retrospective-study-of-chest-tomosynthesis-as-a-tool-for-optimizing-the-use-of-computed-tomography/"><div class="card-body"> <em class="small" data-ts="1414774800" data-df="ll" > Oct 31, 2014 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>A Retrospective Study of Chest Tomosynthesis as a Tool for Optimizing the use of Computed Tomography Resources and Reducing Patient Radiation Exposure</h3><div class="text-muted small"><p> Rationale and Objectives To investigate potential benefits and drawbacks of the clinical use of chest tomosynthesis (CTS), to what extent CTS obviates the need for chest computed tomography (CT), ...</p></div></div></a></div><div class="card"> <a href="/posts/automated-assessment-of-renal-cortical-surface-roughness-from-computerized-tomography-images-and-its/"><div class="card-body"> <em class="small" data-ts="1414774800" data-df="ll" > Oct 31, 2014 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Automated Assessment of Renal Cortical Surface Roughness From Computerized Tomography Images and Its Association with Age</h3><div class="text-muted small"><p> Rationale and Objectives Nephrosclerosis occurs with aging and is characterized by increased kidney subcapsular surface irregularities at autopsy. Assessments of cortical roughness in vivo could p...</p></div></div></a></div><div class="card"> <a href="/posts/breast-mri-bi-rads-assessments-and-abnormal-interpretation-rates-by-clinical-indication-in-us-commun/"><div class="card-body"> <em class="small" data-ts="1414774800" data-df="ll" > Oct 31, 2014 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Breast MRI BI-RADS Assessments and Abnormal Interpretation Rates by Clinical Indication in US Community Practices</h3><div class="text-muted small"><p> Rationale and Objectives As breast magnetic resonance imaging (MRI) use grows, benchmark performance parameters are needed for auditing and quality assurance purposes. We describe the variation in...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/testing-for-interchangeability-of-imaging-tests/" class="btn btn-outline-primary" prompt="Older"><p>Testing for Interchangeability of Imaging Tests</p></a> <a href="/posts/usefulness-of-coronal-reconstruction-ct-images-for-quantitative-evaluation-of-the-cross-sectional-ar/" class="btn btn-outline-primary" prompt="Newer"><p>Usefulness of Coronal Reconstruction CT Images for Quantitative Evaluation of the Cross-Sectional Area of Small Pulmonary Vessels</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
